Efficacy of Early Rhythm Control in AF With TR Patients
Recruiting
Observational Study
Atrial Fibrillation (AF)
Tricuspid Regurgitation (TR)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,800 (estimated)
- Sponsor
- Samsung Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Atrial fibrillation is frequently accompanied by tricuspid regurgitation and may contribute to right atrial and tricuspid annular remodeling, leading to progression of tricuspid regurgitation and adverse clinical outcomes. However, whether early rhythm control improves prognosis in patients with atrial fibrillation and tricuspid regurgitation remains unclear. This study will compare early rhythm c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with concomitant atrial fibrillation and tricuspid regurgitation.
Exclusion Criteria:
* Patients with a history of valvular surgery
* Patients with congenital heart disease
* Patients with primary pulmonary hypertension
* Patients with CIED implantation prior to the…
Contacts